Purchase Order 75N93021P00528

This is a $18,328.50 firm-fixed-price purchase order contract awarded to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies, by the National Institutes of Health (NIH) Clinical Center. The contract is for the provision of reagents and kits to support various research efforts across disease areas including COVID-19, multiple sclerosis, infectious diseases, allergies, immunology, oncology, and bone marrow disorders. Biolegend has a history of federal awards with the...

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $29,645.10 firm fixed price purchase order to Biolegend, Inc. for BIOLEGEND REAGENTS. Biolegend, Inc. is a subsidiary of Revvity Inc. Medical Imaging, LLC. The place of performance will be Biolegend's facilities located in San Diego, California. The period of performance is from June 27, 2023 through September 30, 2023. No additional details were provided regarding subcontractors or the NIH...

Biolegend, Inc. has been awarded a firm fixed price purchase order contract valued at twenty-four thousand five hundred sixty-one dollars and seventy-five cents ($24,561.75) by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract is for the delivery of BIOLEGEND ANTIBODIES with performance through September 30, 2023. As a manufacturer of biomedical reagents, antibodies, proteins, and other products to...

This $5,373.75 firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and other life science research products. The contract is for the delivery of anti-mouse IgM reagents to support NIAID's research initiatives, which may include areas such as COVID-19, multiple sclerosis, and other...

This firm-fixed-price federal purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Biolegend, Inc., a for-profit manufacturer of biomedical products. The $31,957.50 contract supports the supply of various antibodies, reagents, and kits to advance research initiatives across NIAID, with no set-aside designation. Biolegend has a long history of providing specialized products for...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order valued at $21,863.25 to Biolegend, Inc. for BIOLEGEND TOTALSEQ ANTIBODIES. No set-aside designation was used. Performance will occur in San Diego, California with a completion date of May 7, 2024. Biolegend, Inc. is a subsidiary of Revvity Inc.'s Medical Imaging, LLC division. The award is likely associated with research efforts...

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a firm-fixed-price purchase order contract worth $8,377.50 to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies. The contract is for the delivery of "Brilliant Violet Anti-Human Antibodies" to support the agency's research efforts. Biolegend, Inc. is a subsidiary of the parent company Revvity Inc. This contract...

This is a firm fixed-price delivery order awarded by the Defense Health Agency to Gen-Probe Incorporated, a for-profit medical diagnostics company, for the provision of COVID-19 reagents. The contract has a ceiling value of $965,100.00 and an ultimate completion date of November 1, 2020. The contract was awarded under the Coronavirus COVID-19 national interest action code and is not set aside. Gen-Probe is a specialized supplier of molecular diagnostic testing systems, assays, and related...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $100,581.75 firm fixed price purchase order contract to Biolegend, Inc., a manufacturer of biomedical reagents, antibodies, proteins, and other products to support life science research and drug discovery. The contract is for the provision of flow cytometry analysis CD8 reagent supplies to support the agency's research efforts. Biolegend, Inc. is a subsidiary of the for-profit...

This $24,970 firm fixed price purchase order was awarded by the National Heart, Lung and Blood Institute of the National Institutes of Health to BioLegend, Inc., a medical division of Revvity Inc., to supply a custom human antibody panel. The solicitation requested TotalSeq-C Custom Human Panels consisting of 11 pouches with 5 reactions per pouch, for a total of 53 reactions. This antibody panel will support the Laboratory of Myeloid Malignancies' single-cell genomics and proteomics research...